Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside
Author:
Funder
National Institutes of Health (NIH)
Charles L. Edelstein.
Publisher
Elsevier BV
Subject
Urology,Nephrology
Reference47 articles.
1. Autosomal dominant polycystic kidney disease;Gabow;N Engl J Med,1993
2. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells;Nauli;Nat Genet,2003
3. Novel targets for the treatment of autosomal dominant polycystic kidney disease;Belibi;Expert Opin Investig Drugs,2010
4. Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects;Chang;Nephron Clin Pract,2012
5. Polycystic kidney disease;Wilson;N Engl J Med,2004
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease;Frontiers in Pharmacology;2024-05-23
2. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease;Journal of the American Society of Nephrology;2023-11-13
3. Folate conjugated nanomedicines for selective inhibition of mTOR signaling in polycystic kidneys at clinically relevant doses;Biomaterials;2023-11
4. Mechanism of cystogenesis by Cd79a-driven, conditional mTOR activation in developing mouse nephrons;Scientific Reports;2023-01-10
5. Autophagy and Autosomal Dominant Polycystic Kidney Disease;Turkish Journal of Nephrology;2023-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3